share_log
Breakings ·  Jun 25 04:05
VTv Therapeutics Announces Screening of First Patient in Catt1 Pivotal Trial Evaluating Cadisegliatin for Type 1 Diabetes
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment